Skip to main content

J&J To Pay $26.5M In Talc Lawsuit

J&J To Pay $26.5M In Talc Lawsuit

J&J To Pay $26.5M In Talc Lawsuit

Introduction

A California jury ordered Johnson & Johnson (J&J) to pay $26.5 million to a woman who claimed that she developed cancer from using the company's talcum powder that contains asbestos.

As per the court documents, the plaintiff of the latest trial was diagnosed with a deadly and rare form of cancer known as mesothelioma. The cancer is formed due to asbestos exposure. The attorney for the plaintiff alleged that J&J was aware of the asbestos particles present in their talc products, and still the company sold it in the market.

The jury even added $100,000 as punitive damages to the settlement as the company illicitly marketed the talc products, even after knowing that the products are unsafe and cause health problems.

A spokesperson for J&J stated that the jury's decision did not support the scientific evidence, so the company intends to appeal the verdict. The company claimed that its products are safe and asbestos-free. However, J&J has been held guilty for producing unsafe talc products in the past, which resulted in recalling 33,000 bottles in October 2019.

Currently, J&J faces more than 30,000 lawsuits against its baby powder products with similar allegations that the presence of asbestos in the product resulted in ovarian cancer and health problems.

Earlier, an Illinois jury granted a talcum trial verdict in favor of Johnson & Johnson by rejecting the allegations of the family members of the woman who died of ovarian cancer.

As per the court documents, the family members of the woman sought $50 million compensation by alleging that J&J's baby powder and Shower to Shower products are dangerous and resulted in ovarian cancer for the woman.

The 69-year-old woman died in September 2016, eighteen months after being diagnosed with ovarian cancer.

A spokesperson for J&J said in a statement that the verdict displayed careful consideration of the science and facts presented by the attorneys. He even added that the company deeply sympathizes with those who are suffering from cancer and seek answers for the same.

The plaintiff's attorney stated that there is strong evidence to conclude that genital talc leads to ovarian cancer, and the decision will not prevent them from seeking justice for several other women who are victims of the disease because of J&J's negligence and greed.

The verdict came in favor of J&J after a three-week trial in St. Clair County, Illinois.

Earlier, an executive of J&J failed to appear before the court as a witness for cross-examination in a talcum lawsuit. J&J recalled 33,000 bottles of talc-based powder in 2019, and in May 2020, discontinued its sale throughout the U.S.

J&J's talc products are one of the most popular cosmetic products throughout the country. For the past 25 years, over 12,00 women and their families have filed lawsuits against J&J alleging that the company's baby powder causes ovarian cancer.

Asbestos in talcum powder is the major cause of cancer as it is harmful to human health and can cause lifelong ailments. A study even concluded the direct linkage of talc powder to ovarian cancer.

The company is even set to settle $26 billion in the opioid MDL as ordered by the federal judge. The company will pay the settlement amount with three major pharmaceutical distributors, Cardinal, McKesson, and AmerisourceBergen.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Teen E-cigarette Use Hits 10-Year Low

Categories: E-Cigarette: JUUL

Federal officials report a significant decline in teen vaping rates in the U.S., with about half a million fewer middle and high school…

Baltimore, Walgreens Reach Opioid Settlement Totaling $402.5m

Categories: Opioids

The City of Baltimore has reached a settlement with Walgreens over its involvement in the opioid crisis, marking the…

Drug Distributors Reach $300M Opioid Settlement

Categories: Opioids

The three largest U.S. drug distributors—McKesson Corp, Cencora Inc, and Cardinal Health Inc—have agreed to pay $300 million to settle claims by health insurers and benefit plans over their role in fueling the U.S.…

Labor Day Litigation Bonanza!     
Free Trials + 15% Discount!